Literature DB >> 9485068

Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.

N D Mehta1, L M Refolo, C Eckman, S Sanders, D Yager, J Perez-Tur, S Younkin, K Duff, J Hardy, M Hutton.   

Abstract

Mutations in the presenilin 1 (PS1) gene on chromosome 14 are a major cause of autosomal dominant, early-onset Alzheimer's disease. Here, we show that transfecting cells with several mutant, but not wild-type, PS1 cDNAs alters the processing of the amyloid precursor protein (APP) such that more Abeta42(43) is produced, confirming and extending several recent reports. The most effective mutation in this regard was the exon 9 splice-out mutation (delta9). The correlation between the size of the effect on APP processing and the age of onset of disease assessed in families with the mutations was not informative, and the possible reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485068     DOI: 10.1002/ana.410430217

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life.

Authors:  John S K Kauwe; Jun Wang; Sumi Chakraverty; Alison M Goate; Andres F Henao-Martinez
Journal:  Neurosci Lett       Date:  2008-04-15       Impact factor: 3.046

2.  Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.

Authors:  Michael F Wangler; Lawrence T Reiter; Georgianna Zimm; Jennifer Trimble-Morgan; Jane Wu; Ethan Bier
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

3.  The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer's disease model.

Authors:  Qidi He; Guan Huang; Yixin Chen; Xiaoqin Wang; Zhishu Huang; Zuanguang Chen
Journal:  Neurochem Res       Date:  2017-07-01       Impact factor: 3.996

4.  Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase.

Authors:  Linfeng Sun; Rui Zhou; Guanghui Yang; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

5.  Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice.

Authors:  George M Alley; Jason A Bailey; Demao Chen; Balmiki Ray; Lakshman K Puli; Heikki Tanila; Pradeep K Banerjee; Debomoy K Lahiri
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

6.  Twenty Years of Presenilins--Important Proteins in Health and Disease.

Authors:  Jochen Walter
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

7.  Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes.

Authors:  Matthias Cacquevel; Lorène Aeschbach; Jemila Houacine; Patrick C Fraering
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

9.  Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.

Authors:  Dieter Petit; Sara Gutiérrez Fernández; Katarzyna Marta Zoltowska; Thomas Enzlein; Natalie S Ryan; Antoinette O'Connor; Maria Szaruga; Elizabeth Hill; Rik Vandenberghe; Nick C Fox; Lucía Chávez-Gutiérrez
Journal:  Mol Psychiatry       Date:  2022-04-01       Impact factor: 13.437

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.